Negotiating with pharma: lessons from the EU COVID-19 vaccine negotiations
EPHA #A2MDialogues WATCH THE DISCUSSION
18 May 2021
12:00-13:00 CEST
online
Continuing our successful online discussions on key access to medicines (A2M) priorities bringing together thought leaders and policy-makers, academics, industry representatives and NGOs, for a frank discussion of European pharmaceutical policies.
Take part in our #A2MDialogues to share your questions and ideas and help us develop actionable #A2Msolutions for decision-makers in Europe.
A one-on-one interview with Clemens Auer, Special Envoy for Health, Austrian Ministry of Health
#A2MDialogues
Clemens Auer
Special Envoy for Health
Austrian Ministry of Health
Interviewed by
Yannis Natsis
Policy Manager, Universal Access and Affordable Medicines
European Public Health Alliance
Catch up on EPHA’s other #A2MDialogues below
Sustainable access to effective antibiotics - what should the EU do?
15 April 2021
After COVID-19, what's next for EU medicines policies?
9 March 2021
Getting it right: Recommendations for a European BARDA
8 December 2020
The Presidencies’ perspective on the pharmaceutical strategy: Europe’s to-do list on access to medicines
25 November 2020
Pharma & COVID19: Winners, losers, prospects
19 November 2020
The EU's IP strategy: Enabler or barrier?
27 October 2020
Unleashing meaningful innovation through regulatory reform
19 October 2020
